Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants

NCT01421121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Viral, Enterovirus

Interventions

BIOLOGICAL: 100U EV71 vaccine with adjuvant
BIOLOGICAL: 200 U EV71 vaccine with adjuvant
BIOLOGICAL: 400U EV71 vaccine with adjuvant
BIOLOGICAL: 200U EV71 vaccine without adjuvant
BIOLOGICAL: Placebo

Sponsor

Sinovac Biotech Co., Ltd